FDA Amends Labeling Regulations for Biological Products to Allow Distributor Names to be Prominently Displayed

Summary

The FDA is updating its labeling requirements for biological products to give distributors more prominence on product labels, aiming to simplify manufacturing, packaging, and distribution processes while aligning with regulations for licensed biologic products and FDA-approved drugs.